APO Research
Talk to an analyst

APO RESEARCH · REPORT

Allergy Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Allergy Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026180 pages

Choose your research edition.

Industry ResearchAllergy Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Allergy Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Allergy Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allergy Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Allergy Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Allergy Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Allergy Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Allergy Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Allergy Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Allergy Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Allergy Vaccine include ALK-Abello, Allergy Therapeutics, HAL, Holister Stier, Leti, Stallergenes Greer, WOLW Pharma and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Allergy Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Allergy Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Allergy Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Allergy Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Allergy Vaccine Segment by Company

ALK-Abello

Allergy Therapeutics

HAL

Holister Stier

Leti

Stallergenes Greer

WOLW Pharma

Merck

Allergy Vaccine Segment by Type

Subcutaneous Immunotherapy

Sublingual Immunotherapy

Allergy Vaccine Segment by Application

Allergic Rhinitis

Allergic Asthma

Other

Allergy Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allergy Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Allergy Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Allergy Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Allergy Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Allergy Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Allergy Vaccine Industry Trends Table 2. Allergy Vaccine Industry Drivers Table 3. Allergy Vaccine Industry Opportunities and Challenges Table 4. Allergy Vaccine Industry Restraints Table 5. Global Allergy Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Allergy Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Allergy Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Allergy Vaccine Sales Market Share by Manufacturers Table 9. Global Allergy Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Allergy Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Allergy Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Allergy Vaccine Manufacturers, Product Type & Application Table 13. Global Allergy Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Allergy Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Subcutaneous Immunotherapy Table 17. Major Manufacturers of Sublingual Immunotherapy Table 18. Global Allergy Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Allergy Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Allergy Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Allergy Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Allergy Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Allergy Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Allergy Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Allergy Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Allergy Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Allergy Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Allergic Rhinitis Table 29. Major Manufacturers of Allergic Asthma Table 30. Major Manufacturers of Other Table 31. Global Allergy Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Allergy Vaccine Sales by Application (2021-2026) & (K Units) Table 33. Global Allergy Vaccine Sales by Application (2027-2032) & (K Units) Table 34. Global Allergy Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Allergy Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Allergy Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Allergy Vaccine Revenue by Application (2021-2026) & (K Units) Table 38. Global Allergy Vaccine Revenue by Application (2027-2032) & (K Units) Table 39. Global Allergy Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Allergy Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Allergy Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Allergy Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Allergy Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Allergy Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Allergy Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Allergy Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Allergy Vaccine Sales by Country (2021-2026) & (K Units) Table 48. North America Allergy Vaccine Sales by Country (2027-2032) & (K Units) Table 49. Europe Allergy Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Allergy Vaccine Sales by Country (2021-2026) & (K Units) Table 51. Europe Allergy Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Allergy Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Allergy Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Allergy Vaccine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Allergy Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Allergy Vaccine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Allergy Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Allergy Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Allergy Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Allergy Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Allergy Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Allergy Vaccine Revenue Market Share by Region (2027-2032) Table 63. ALK-Abello Company Information Table 64. ALK-Abello Business Overview Table 65. ALK-Abello Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ALK-Abello Allergy Vaccine Product Portfolio Table 67. ALK-Abello Recent Development Table 68. Allergy Therapeutics Company Information Table 69. Allergy Therapeutics Business Overview Table 70. Allergy Therapeutics Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Allergy Therapeutics Allergy Vaccine Product Portfolio Table 72. Allergy Therapeutics Recent Development Table 73. HAL Company Information Table 74. HAL Business Overview Table 75. HAL Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. HAL Allergy Vaccine Product Portfolio Table 77. HAL Recent Development Table 78. Holister Stier Company Information Table 79. Holister Stier Business Overview Table 80. Holister Stier Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Holister Stier Allergy Vaccine Product Portfolio Table 82. Holister Stier Recent Development Table 83. Leti Company Information Table 84. Leti Business Overview Table 85. Leti Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Leti Allergy Vaccine Product Portfolio Table 87. Leti Recent Development Table 88. Stallergenes Greer Company Information Table 89. Stallergenes Greer Business Overview Table 90. Stallergenes Greer Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Stallergenes Greer Allergy Vaccine Product Portfolio Table 92. Stallergenes Greer Recent Development Table 93. WOLW Pharma Company Information Table 94. WOLW Pharma Business Overview Table 95. WOLW Pharma Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. WOLW Pharma Allergy Vaccine Product Portfolio Table 97. WOLW Pharma Recent Development Table 98. Merck Company Information Table 99. Merck Business Overview Table 100. Merck Allergy Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Merck Allergy Vaccine Product Portfolio Table 102. Merck Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Allergy Vaccine Distributors List Table 106. Allergy Vaccine Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Allergy Vaccine Product Image Figure 2. Global Allergy Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allergy Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Allergy Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Allergy Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Allergy Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Subcutaneous Immunotherapy Image Figure 9. Sublingual Immunotherapy Image Figure 10. Global Allergy Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Allergy Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Allergy Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Allergy Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Allergy Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Allergy Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Allergic Rhinitis Image Figure 17. Allergic Asthma Image Figure 18. Other Image Figure 19. Global Allergy Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Allergy Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Allergy Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Allergy Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Allergy Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Allergy Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Allergy Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Allergy Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Allergy Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Allergy Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Allergy Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Allergy Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Allergy Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Allergy Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Allergy Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Allergy Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Allergy Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Allergy Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Allergy Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Allergy Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Allergy Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Allergy Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Allergy Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy
Applications
  • Allergic Rhinitis
  • Allergic Asthma
  • Other
Companies covered
  • ALK-Abello
  • Allergy Therapeutics
  • HAL
  • Holister Stier
  • Leti
  • Stallergenes Greer
  • WOLW Pharma
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Allergy Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Allergy Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Allergy Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Allergy Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Allergy Vaccine Market Dynamics
  1. 2.1 Allergy Vaccine Industry Trends
  2. 2.2 Allergy Vaccine Industry Drivers
  3. 2.3 Allergy Vaccine Industry Opportunities and Challenges
  4. 2.4 Allergy Vaccine Industry Restraints
3 Allergy Vaccine Market by Manufacturers
  1. 3.1 Global Allergy Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Allergy Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Allergy Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Allergy Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Allergy Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Allergy Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Allergy Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Allergy Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Allergy Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Allergy Vaccine Tier 1, Tier 2, and Tier 3
4 Allergy Vaccine Market by Type
  1. 4.1 Allergy Vaccine Type Introduction
  2. 4.1.1 Subcutaneous Immunotherapy
  3. 4.1.2 Sublingual Immunotherapy
  4. 4.2 Global Allergy Vaccine Sales by Type
  5. 4.2.1 Global Allergy Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Allergy Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Allergy Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Allergy Vaccine Revenue by Type
  9. 4.3.1 Global Allergy Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Allergy Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Allergy Vaccine Revenue Market Share by Type (2021-2032)
5 Allergy Vaccine Market by Application
  1. 5.1 Allergy Vaccine Application Introduction
  2. 5.1.1 Allergic Rhinitis
  3. 5.1.2 Allergic Asthma
  4. 5.1.3 Other
  5. 5.2 Global Allergy Vaccine Sales by Application
  6. 5.2.1 Global Allergy Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Allergy Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Allergy Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Allergy Vaccine Revenue by Application
  10. 5.3.1 Global Allergy Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Allergy Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Allergy Vaccine Revenue Market Share by Application (2021-2032)
6 Global Allergy Vaccine Sales by Region
  1. 6.1 Global Allergy Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Allergy Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Allergy Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Allergy Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Allergy Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Allergy Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Allergy Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Allergy Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Allergy Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Allergy Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Allergy Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Allergy Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Allergy Vaccine Revenue by Region
  1. 7.1 Global Allergy Vaccine Revenue by Region
  2. 7.1.1 Global Allergy Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Allergy Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Allergy Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Allergy Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Allergy Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Allergy Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Allergy Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Allergy Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Allergy Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Allergy Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Allergy Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Allergy Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ALK-Abello
  2. 8.1.1 ALK-Abello Company Information
  3. 8.1.2 ALK-Abello Business Overview
  4. 8.1.3 ALK-Abello Allergy Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ALK-Abello Allergy Vaccine Product Portfolio
  6. 8.1.5 ALK-Abello Recent Developments
  7. 8.2 Allergy Therapeutics
  8. 8.2.1 Allergy Therapeutics Company Information
  9. 8.2.2 Allergy Therapeutics Business Overview
  10. 8.2.3 Allergy Therapeutics Allergy Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Allergy Therapeutics Allergy Vaccine Product Portfolio
  12. 8.2.5 Allergy Therapeutics Recent Developments
  13. 8.3 HAL
  14. 8.3.1 HAL Company Information
  15. 8.3.2 HAL Business Overview
  16. 8.3.3 HAL Allergy Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 HAL Allergy Vaccine Product Portfolio
  18. 8.3.5 HAL Recent Developments
  19. 8.4 Holister Stier
  20. 8.4.1 Holister Stier Company Information
  21. 8.4.2 Holister Stier Business Overview
  22. 8.4.3 Holister Stier Allergy Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Holister Stier Allergy Vaccine Product Portfolio
  24. 8.4.5 Holister Stier Recent Developments
  25. 8.5 Leti
  26. 8.5.1 Leti Company Information
  27. 8.5.2 Leti Business Overview
  28. 8.5.3 Leti Allergy Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Leti Allergy Vaccine Product Portfolio
  30. 8.5.5 Leti Recent Developments
  31. 8.6 Stallergenes Greer
  32. 8.6.1 Stallergenes Greer Company Information
  33. 8.6.2 Stallergenes Greer Business Overview
  34. 8.6.3 Stallergenes Greer Allergy Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Stallergenes Greer Allergy Vaccine Product Portfolio
  36. 8.6.5 Stallergenes Greer Recent Developments
  37. 8.7 WOLW Pharma
  38. 8.7.1 WOLW Pharma Company Information
  39. 8.7.2 WOLW Pharma Business Overview
  40. 8.7.3 WOLW Pharma Allergy Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 WOLW Pharma Allergy Vaccine Product Portfolio
  42. 8.7.5 WOLW Pharma Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck Allergy Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck Allergy Vaccine Product Portfolio
  48. 8.8.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Allergy Vaccine Value Chain Analysis
  2. 9.1.1 Allergy Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Allergy Vaccine Production Mode & Process
  6. 9.2 Allergy Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Allergy Vaccine Distributors
  9. 9.2.3 Allergy Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst